| Contraceptive | Approval time, d (order of submission date*) | ||
|---|---|---|---|
| Canada | US | UK | |
| Yasmin (Canada, US, UK) | 1926 (2) | 728 (1) | 212 (3) |
| Seasonale (Canada, US, UK) | 561 (2) | 396 (1) | NA |
| Natazia (Canada, US), Qlaira (UK) | 775 (3) | 308 (2) | 361 (1) |
| Ortho-Evra (Canada, US, UK) | 505 (3) | 334 (1) | 528 (2) |
| NuvaRing (Canada, US, UK) | 554 (2) | 645 (1) | 465 (3) |
| Implanon, Nexplanon (US, UK) | NA | 1021 (1) | 78 (2) |
| ella (Canada, US), ellaOne (UK) | 452 (3) | 306 (2) | 715 (1) |
| Mirena (Canada, US, UK) | 709 (2) | 310 (3) | 58 (1) |
Note: NA = not available.
*Order of submission date is ranked by the date when the application for a novel contraceptive was submitted for approval; "1" represents the country that submitted the earliest, "2" the next earliest and "3" the latest.